[Liposomal doxorubicin and palmoplantar erythrodysesthesia].
Tomb
R
R
Stephan
F
F
Halaby
G
G
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D003873:Dermatitis, Exfoliative / Q000139:chemically induced*; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D005533:Foot Dermatoses / Q000139:chemically induced*; D006229:Hand Dermatoses / Q000139:chemically induced*; D006801:Humans; D008081:Liposomes; D008875:Middle Aged; D010292:Paresthesia / Q000139:chemically induced*
D000903:Antibiotics, Antineoplastic; D008081:Liposomes; D004317:Doxorubicin